 | 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | IC50 | 11.1 [1] |
 | Olaparib | IC50 | 1230.27 [1], 1500.0 [2], 1800.0 [3], 1900.0 [4], 3534.0 [5] |
 | (4S)-3-[4-(6-Amino-5-pyrimidin-2-ylpyridin-3-yl)cyclohexyl]-5,5-dimethyl-4-phenyl-1,3-oxazolidin-2-one | IC50 | 1.47 [1], 2.0 [2], 370.0 [3] |
 | N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide | IC50 | 570.0 [1], 1300.0 [2], 1698.24 [3] |
 | IWR-1-endo | IC50 | 131.0 [1], 150.0 [2], 151.0 [3] |
 | 4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-quinolin-8-ylcyclohexane-1-carboxamide | IC50 | 16.0 [1], 16.8 [2], 5200.0 [3] |
 | [4-(1-Methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 2.51 [1], 31.62 [2] |
 | (4-Pyrimidin-2-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 7.94 [1], 15.85 [2], 19.95 [3] |
 | 3-(4-(Dimethylaminomethyl)phenyl)isoquinoline-1(2H)-one | IC50 | 18.0 [1], 10000.0 [2] |
 | 3-(4-(Dimethylaminomethyl)phenyl)-5-methylisoquinoline-1(2H)-one | IC50 | 12.0 [1], 72.0 [2] |
 | Flavone | IC50 | 320.0 [1], 330.0 [2] |
 | Veliparib | IC50 | 10000.0 [1], 10715.19 [2] |
 | Rucaparib | IC50 | 25.0 [1], 144.54 [2] |
 | Niraparib | IC50 | 570.0 [1], 2344.23 [2] |
 | 4H-Thieno[2,3-c]isoquinolin-5-one | IC50 | 200.0 [1], 100000.0 [2] |
 | 2-Phenylquinazolin-4-ol | IC50 | 59.0 [1], 1406.0 [2] |
 | 4'-Fluoroflavone | IC50 | 280.0 [1], 700.0 [2] |
 | 2-(4-Chlorophenyl)quinazolin-4-ol | IC50 | 140.0 [1], 485.0 [2] |
 | N-Phenyltetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 251.19 [1], 1995.26 [2] |
 | 4,4'-Oxydibenzamide | IC50 | 100000.0 [1] |
 | 2-(4-Methylphenyl)-4H-chromen-4-one | IC50 | 47.0 [1], 52.0 [2] |
 | N-(3-Methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine | IC50 | 10000.0 [1], 15848.93 [2] |
 | N-(4-Chlorophenyl)tetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 398.11 [1], 1258.93 [2] |
 | N-(4-Methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine | IC50 | 125.89 [1], 1258.93 [2] |
 | Morpholin-4-Yl[4-(Tetrazolo[1,5-A]quinoxalin-4-Ylamino)phenyl]methanone | IC50 | 50.12 [1], 158.49 [2] |
 | 4-[(1R,2S,6R,7S)-3,5-Dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]-N-(4-methylquinolin-8-yl)benzamide | IC50 | 160.0 [1], 192.0 [2] |
 | 5H-Benzothiopheno[2,3-c]quinolin-6-one | IC50 | 90.0 [1] |
 | N-(2-Methoxyphenyl)-4-{[3-(4-Oxo-3,4-Dihydroquinazolin-2-Yl)propanoyl]amino}benzamide | IC50 | 8.0 [1], 10.0 [2] |
 | 2-[4-(Trifluoromethyl)phenyl]-3h-Quinazolin-4-One | IC50 | 50.0 [1], 425.0 [2] |
 | 2-[4-(Trifluoromethyl)phenyl]-3,5,6,8-tetrahydrothiopyrano[3,4-d]pyrimidin-4-one | IC50 | 11.0 [1], 5000.0 [2] |
 | 4-N,4-N-Dimethyl-1-N-(tetrazolo[1,5-a]quinoxalin-4-yl)benzene-1,4-diamine | IC50 | 63.1 [1], 1258.93 [2] |
 | N-(2-Methoxyphenyl)-4-[3-(4-oxo-3H-quinazolin-2-yl)propanoylamino]cyclohexane-1-carboxamide | IC50 | 31.0 [1], 7460.0 [2] |
 | [4-(Oxan-4-yl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 31.62 [1], 251.19 [2] |
 | Morpholin-4-yl-[3-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 10000.0 [1] |
 | N-(3-Propan-2-ylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 10000.0 [1], 199526.23 [2] |
 | [3-Fluoro-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]-morpholin-4-ylmethanone | IC50 | 7943.28 [1], 10000.0 [2] |
 | N-(2-Methylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 10000.0 [1], 63095.73 [2] |
 | (4-Pyrimidin-4-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 2.0 [1], 6.31 [2] |
 | N-(4-Propan-2-ylphenyl)tetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 125.89 [1], 199.53 [2] |
 | (4-Pyridin-2-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 31.62 [1], 100.0 [2] |
 | N-(4-Fluorophenyl)tetrazolo[1,5-a]quinoxalin-4-amine | IC50 | 630.96 [1], 3981.07 [2] |
 | N-[4-(Tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]acetamide | IC50 | 19.95 [1], 251.19 [2] |
 | 4-[(4s)-5,5-Dimethyl-2-Oxo-4-Phenyl-1,3-Oxazolidin-3-Yl]-N-(Quinolin-8-Yl)benzamide | IC50 | 198.0 [1], 200.0 [2] |
 | 4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(1,5-naphthyridin-4-yl)benzamide | IC50 | 18.0 [1], 18.3 [2] |
 | N-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]quinoline-8-carboxamide | IC50 | 10.0 [1], 22.0 [2] |
 | N-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-1,5-naphthyridine-4-carboxamide | IC50 | 4.0 [1], 4.56 [2] |
 | N-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-7-fluoro-1,5-naphthyridine-4-carboxamide | IC50 | 3.86 [1], 4.0 [2] |
 | (4S)-5,5-Dimethyl-3-[4-(2-oxo-3H-imidazo[4,5-c]pyridin-1-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 3.0 [1], 3.04 [2] |
 | (4S)-5,5-Dimethyl-3-[4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 10.7 [1], 11.0 [2] |
 | 1-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-2-oxo-3H-benzimidazole-5-carbonitrile | IC50 | 1.0 [1], 1.12 [2] |
 | 1-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-2-oxo-3H-benzimidazole-4-carbonitrile | IC50 | 3.56 [1], 4.0 [2] |
 | 1-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-6-fluoro-2-oxo-3H-benzimidazole-5-carbonitrile | IC50 | 3.0 [1], 3.48 [2] |
 | 1-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-4-fluoro-2-oxo-3H-benzimidazole-5-carbonitrile | IC50 | 1.0 [1], 1.09 [2] |
 | 3-[4-[(4S)-5,5-Dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]-2-oxo-1H-imidazo[4,5-b]pyridine-6-carbonitrile | IC50 | 143.0 [1] |
 | (4S)-5,5-Dimethyl-3-[4-(2-oxo-1H-imidazo[4,5-b]pyridin-3-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 4.0 [1], 11.8 [2] |
 | (4S)-5,5-Dimethyl-3-[4-(2-oxo-1H-imidazo[4,5-c]pyridin-3-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 4.0 [1], 4.07 [2] |
 | (4S)-5,5-Dimethyl-3-[4-(8-oxo-7H-purin-9-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 5.0 [1], 5.11 [2] |
 | (4s)-3-{4-[6-Amino-5-(Pyrimidin-2-Yl)pyridin-3-Yl]phenyl}-5,5-Dimethyl-4-Phenyl-1,3-Oxazolidin-2-One | IC50 | 49.0 [1] |
 | 4-[[1-[[2-Cyano-3-(trifluoromethyl)phenyl]methyl]-2,4-dioxoquinazolin-3-yl]methyl]cyclohexane-1-carboxylic acid | IC50 | 7.94 [1], 31.62 [2] |
 | 4-[[1-[[2-Cyano-3-(trifluoromethyl)phenyl]methyl]-6-fluoro-5-methyl-2,4-dioxoquinazolin-3-yl]methyl]cyclohexane-1-carboxylic acid | IC50 | 6.31 [1], 50.12 [2] |
 | 2-Amino-5-[4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexyl]pyridine-3-carbonitrile | IC50 | 6.98 [1], 9.0 [2] |
 | Cyclopropyl-[4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]methanone | IC50 | 19.95 [1], 5011.87 [2] |
 | [4-(1H-Pyrazole-5-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 10.0 [1], 125.89 [2] |
 | [4-(3-Methylimidazole-4-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 25.12 [1], 398.11 [2] |
 | [4-(1H-Imidazole-5-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 3.98 [1], 251.19 [2] |
 | 1-[4-[4-(Tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]ethanone | IC50 | 15.85 [1], 125.89 [2] |
 | (4-Pyridin-3-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 25.12 [1], 63.1 [2] |
 | Tnks-IN-41 | IC50 | 7.94 [1], 100.0 [2] |
 | [4-(Pyrimidine-2-carbonyl)piperazin-1-yl]-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 15.85 [1], 398.11 [2] |
 | N-(2-Methoxyethyl)-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzamide | IC50 | 199.53 [1], 630.96 [2] |
 | (4-Pyridin-4-ylpiperazin-1-yl)-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 6.31 [1], 125.89 [2] |
 | 4-(Tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoic acid | IC50 | 398.11 [1], 10000.0 [2] |
 | Piperazin-1-yl-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 50.12 [1], 794.33 [2] |
 | N-(2-Methoxyethyl)-N-methyl-4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzamide | IC50 | 19.95 [1], 79.43 [2] |
 | 1-[4-(Tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]pyrrolidin-2-one | IC50 | 7.94 [1], 100.0 [2] |
 | 4-[4-(Tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]morpholin-3-one | IC50 | 7.94 [1], 100.0 [2] |
 | N-Methyl-N-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]acetamide | IC50 | 10.0 [1], 79.43 [2] |
 | Piperidin-1-yl-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)phenyl]methanone | IC50 | 63.1 [1], 501.19 [2] |
 | Oxan-4-yl-[4-[4-(tetrazolo[1,5-a]quinoxalin-4-ylamino)benzoyl]piperazin-1-yl]methanone | IC50 | 25.12 [1], 199.53 [2] |
 | 3-(4-(3-(Dimethylamino)azetidine-1-ylmethyl)phenyl)-5-methylisoquinoline-1(2H)-one | IC50 | 21.0 [1], 35.0 [2] |
 | 3-(4-(Trifluoromethyl)phenyl)-5-chloroisoquinoline-1(2H)-one | IC50 | 128.0 [1], 483.0 [2] |
 | 3-(4-Fluorophenyl)-5-methoxyisoquinoline-1(2H)-one | IC50 | 104.0 [1], 120.0 [2] |
 | 3-(4-(Dimethylaminomethyl)phenyl)-5-chloroisoquinoline-1(2H)-one | IC50 | 151.0 [1], 364.0 [2] |
 | 3-(4-(Dimethylaminomethyl)phenyl)-5-fluoroisoquinoline-1(2H)-one | IC50 | 16.0 [1], 1730.0 [2] |
 | 3-(4-(Morpholinomethyl)phenyl)-5-methylisoquinoline-1(2H)-one | IC50 | 12.0 [1], 25.0 [2] |
 | 3-(4-(4-Methylpiperazinomethyl)phenyl)-5-methylisoquinoline-1(2H)-one | IC50 | 17.0 [1], 43.0 [2] |
 | 3-(4-{[4-(Dimethylamino)piperidin-1-Yl]methyl}phenyl)-5-Methylisoquinolin-1(2h)-One | IC50 | 13.0 [1], 61.0 [2] |
 | 5-Methyl-3-[4-(Piperazin-1-Ylmethyl)phenyl]isoquinolin-1(2h)-One | IC50 | 17.0 [1], 117.0 [2] |
 | 3-(4-Methylphenyl)-5-methoxyisoquinoline-1(2H)-one | IC50 | 34.0 [1], 59.0 [2] |
 | (4S)-5,5-Dimethyl-3-[4-(6-oxo-5-pyrimidin-2-yl-1H-pyridin-3-yl)cyclohexyl]-4-phenyl-1,3-oxazolidin-2-one | IC50 | 267.0 [1], 511.0 [2] |
 | (4S)-3-[4-[6-Amino-5-(1,4,5,6-tetrahydropyrimidin-2-yl)pyridin-3-yl]cyclohexyl]-5,5-dimethyl-4-phenyl-1,3-oxazolidin-2-one | IC50 | 1650.0 [1], 9840.0 [2] |
 | (4S)-5,5-Dimethyl-4-phenyl-3-[4-(1H-pyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one | IC50 | 19.0 [1], 1250.0 [2] |
 | 3-{4-[(Dimethylamino)methyl]phenyl}-5-Methoxyisoquinolin-1(2h)-One | IC50 | 19.0 [1], 136.0 [2] |
 | Apigenin | IC50 | 3100.0 [1] |
 | Luteolin | IC50 | 2400.0 [1] |
 | 6(5H)-Phenanthridinone | IC50 | 110.0 [1] |
 | Bmn-673 8R,9S | IC50 | 323.59 [1] |
 | 3',4'-Dihydroxyflavone | IC50 | 230.0 [1] |
 | 4'-Methoxyflavone | IC50 | 71.0 [1] |
 | 7,3',4'-Trihydroxyflavone | IC50 | 630.0 [1] |
Calculator
